Cyclosporin neurotoxicity after chemotherapy

BMJ

Volumn 319, Issue 7201, 1999, Pages 54-

  Pratt, Guy ^a   Kennedy, Ben ^a   Smith, Graeme ^a   Lewis, M B ^b   Tweddle, Deborah A ^c   Windebank, Kevin P ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b University Hospital   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLOOD BRAIN BARRIER; BLOOD CELL COUNT; BLOOD PRESSURE MEASUREMENT; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FEVER; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; KIDNEY DISEASE; LETTER; LEUKOENCEPHALOPATHY; LYMPHOPROLIFERATIVE DISEASE; NEUROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0033519944     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.319.7201.54     Document Type: Letter

References (12)

1. Tweddle DA, Windebank KP, Hewson QC, Yule SM. BMJ 1999; 318: 1113. (24 April.)
2. Bonser AS, Adu D, Franklin I, McMaster P. Cyclosporin induced haemolytic uraemic syndrome in liver allograft recipient. Lancet 1984; 2: 1337.
3. Beaufils H, de Groc F, Gubler MC, Wechsler B, Le Hoang P, Baumelou A, et al. Hemolytic uremic syndrome in patients with Behcet's disease treated with cyclosporin A; report of 2 cases. Clin Nephrol 1990; 34: 157–162.
4. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, et al. Cancer-associated hemolytic-uremic syndrome: an analysis of 85 cases from a national registry. J Clin Oncol 1989; 7: 781–789.
5. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495–504.
6. Tweddle DA, Windebank KP, Hewson QC, Yule SM. BMJ 1999; 318: 1113. (24 April.)
7. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494–500.
8. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, et al. Posterior leukoencephalopathy without severe hypertension. Neurology 1998; 51: 1369–1376.
9. Benigni A, Morigi M, Perico N, Zoja C, Amuchastegui CS, Piccinelli A, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992; 54: 775–780.
10. Barbui T, Rambaldi A, Parenzan L, Zucchelli M, Perico N, Remuzzi G. Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapy. Lancet 1992; 339: 1421.
11. Tweddle DA, Gennery AR, Reid MM, Thomas JA, Burke M, Hamilton JRL, et al. Posttransplantation B lymphoblastic leukemia with Burkitt-like features. Transplantation 1999; 67: 1379–1380.
12. Lucey MR, Kolars JC, Merion RM, Campbell DA, Aldrich M, Watkins PB. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450IIIIA. Lancet 1990; 335: 11–15.